The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Market Size Of The Liver Cirrhosis Market In 2026 And What Value Is Projected For 2030?
The liver cirrhosis market has experienced significant expansion in recent years. It is projected to grow from $1.99 billion in 2025 to $2.15 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 7.8%. This historical growth can be attributed to factors such as chronic alcohol consumption patterns, widespread hepatitis B and C infections, limited early detection of liver damage, a rising incidence of fatty liver disease, and a historical lack of curative treatment options.
The liver cirrhosis market size is anticipated to undergo substantial growth in the upcoming years. It is projected to reach $2.88 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.7%. This expansion during the forecast timeframe is primarily driven by factors such as the increasing burden of NASH and metabolic syndrome, heightened recognition of liver health, broader availability of diagnostic testing, a surge in demand for advanced liver care, and augmented healthcare expenditure on chronic diseases. Key trends expected within the forecast duration encompass the escalating prevalence of chronic liver diseases, an intensified emphasis on prompt diagnosis and disease monitoring, a heightened call for long-term disease management, the proliferation of supportive and symptom-based therapies, and a growing requirement for specialized hepatology care.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=22040&type=smp
What Major Drivers Are Influencing Demand In The Liver Cirrhosis Market?
Rising alcohol consumption is anticipated to propel the growth of the liver cirrhosis market going forward. Alcohol consumption denotes the intake of alcoholic beverages, typically assessed by quantity and frequency. Individuals are increasingly consuming alcohol because it aids in unwinding from daily stress, strengthens social bonds in gatherings, and improves moments of relaxation, additionally benefiting from widespread media promotion and enhanced accessibility in various settings. For patients with excessive alcohol consumption, liver cirrhosis treatment focuses on managing liver damage through abstinence, prescribed medications, and supportive care, concurrently addressing alcohol dependence with counseling and rehabilitation. For instance, in December 2024, data from the Bureau of Labor Statistics, a US-based government agency, indicated that in 2023, U.S. households spent an average of $294 on alcoholic beverages consumed at home and $343 on those consumed outside the home. Therefore, increasing alcohol consumption drives the liver cirrhosis market.
What Are The Key Segments Of The Liver Cirrhosis Market?
The liver cirrhosis market covered in this report is segmented –
1) By Type: Alcoholic Cirrhosis, Biliary Cirrhosis, Cardiac Cirrhosis, Cryptogenic Cirrhosis
2) By Treatment: Antibiotics, Immunosuppressants, Other Treatments
3) By End Users: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Academic And Research Institutes, Other End Users
Subsegments:
1) By Alcoholic Cirrhosis: Compensated Alcoholic Cirrhosis, Decompensated Alcoholic Cirrhosis, Alcoholic Steatohepatitis (ASH)-Associated Cirrhosis
2) By Biliary Cirrhosis: Primary Biliary Cirrhosis (PBC), Secondary Biliary Cirrhosis, Autoimmune Biliary Cirrhosis
3) By Cardiac Cirrhosis: Right Heart Failure-Induced Cirrhosis, Chronic Passive Congestion Cirrhosis, Ischemic Hepatitis Cirrhosis
4) By Cryptogenic Cirrhosis: Non-Alcoholic Steatohepatitis (NASH)-Associated Cirrhosis, Idiopathic Cirrhosis, Metabolic Syndrome-Associated Cirrhosis
What Major Market Trends Are Driving Changes In The Liver Cirrhosis Market?
Companies active in the liver cirrhosis market are concentrating on advancements in treatment, including the development of active implantable medical devices, to enhance patient outcomes and expand therapeutic options. Active implantable medical devices are electronic implants specifically engineered to monitor, support, or improve organ function within the body. As an illustration, in December 2024, Sequana Medical NV, a Belgium-based medical device company, secured U.S. FDA approval for its alfapump system, which is the first active implantable medical device approved in the U.S. for handling recurrent or refractory ascites caused by liver cirrhosis. This innovative technology provides a continuous, automated solution for fluid management by transferring surplus abdominal fluid to the bladder, significantly decreasing the need for invasive therapeutic paracentesis. The alfapump represents a notable improvement in boosting patient outcomes and elevating their quality of life, addressing a market of approximately 70,000 patients in the United States.
Who Are The Leading Companies Operating In The Liver Cirrhosis Market?
Major companies operating in the liver cirrhosis market are F Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific Inc., Siemens Healthineers AG, GE HealthCare Technologies Inc., Fujifilm Holdings Corporation, Canon Medical Systems Corporation, Koninklijke Philips N.V., Samsung Medison Co. Ltd., Mindray Medical International Limited, Boston Scientific Corporation, Olympus Corporation, Echosens SA, Hologic Inc., Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., bioMérieux SA, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Perspectum Diagnostics Ltd., Owlstone Medical Ltd.
Read the full liver cirrhosis market report here:
https://www.thebusinessresearchcompany.com/report/liver-cirrhosis-global-market-report
Which Region Shows The Strongest Potential For Future Growth In The Liver Cirrhosis Market?
North America was the largest region in the liver cirrhosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the liver cirrhosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Liver Cirrhosis Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=22040&type=smp
Browse Through More Reports Similar to the Global Liver Cirrhosis Market 2026, By The Business Research Company
Liver Health Supplements Global Market Report
https://www.thebusinessresearchcompany.com/report/liver-health-supplements-global-market-report
Liver Cancer Diagnostics Global Market Report
https://www.thebusinessresearchcompany.com/report/liver-cancer-diagnostics-global-market-report
Hepatic Encephalopathy Global Market Report
https://www.thebusinessresearchcompany.com/report/hepatic-encephalopathy-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model